Literature DB >> 8627794

Characterization of chimeras between the ecotropic Moloney murine leukemia virus and the amphotropic 4070A envelope proteins.

C Peredo1, L O'Reilly, K Gray, M J Roth.   

Abstract

A series of 22 chimeric envelope (env) genes were generated between the ecotropic Moloney murine leukemia virus and the amphotropic 4070A isolate. The chimeric envelopes were expressed within the complete, replication-competent provirus and tested for virus viability by transient expression assays. Eleven of the 22 viruses were viable. Five of these chimeric viruses showed an ecotropic host range, and six exhibited an amphotropic host range and viral interference. The host range determinants map to the first half of the surface (SU) protein. The N-terminal 72 amino acids of 4070A (42 of processed SU) are not required for amphotropic receptor usage. Ecotropic and amphotropic viruses differ in their ability to form large, multinucleated syncytia when cocultured with the rat XC cell line. Ecotropic murine leukemia virus forms large syncytia with XC cells, whereas no syncytia are reported for amphotropic virus. All chimeras which contained the N-terminal half of the ecotropic SU protein, encoding the receptor binding domain, formed the large multinucleated syncytia with XC cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627794      PMCID: PMC190177     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  Retrovirus-induced cell fusion is enhanced by protease treatment.

Authors:  K B Andersen; H Skov
Journal:  J Gen Virol       Date:  1989-07       Impact factor: 3.891

2.  Construction and use of a safe and efficient amphotropic packaging cell line.

Authors:  D Markowitz; S Goff; A Bank
Journal:  Virology       Date:  1988-12       Impact factor: 3.616

3.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel; J D Roberts; R A Zakour
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

4.  Retroviral vector particles displaying the antigen-binding site of an antibody enable cell-type-specific gene transfer.

Authors:  T H Chu; R Dornburg
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

5.  Gene product of Moloney murine leukemia virus required for proviral integration is a DNA-binding protein.

Authors:  M J Roth; N Tanese; S P Goff
Journal:  J Mol Biol       Date:  1988-09-05       Impact factor: 5.469

6.  Sequence analysis of amphotropic and 10A1 murine leukemia viruses: close relationship to mink cell focus-inducing viruses.

Authors:  D Ott; R Friedrich; A Rein
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

7.  The pH independence of mammalian retrovirus infection.

Authors:  M O McClure; M A Sommerfelt; M Marsh; R A Weiss
Journal:  J Gen Virol       Date:  1990-04       Impact factor: 3.891

8.  A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection.

Authors:  L M Albritton; L Tseng; D Scadden; J M Cunningham
Journal:  Cell       Date:  1989-05-19       Impact factor: 41.582

9.  Construction and characterization of the recombinant Moloney murine leukemia viruses bearing the mouse Fv-4 env gene.

Authors:  M Masuda; H Yoshikura
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

10.  A safe packaging line for gene transfer: separating viral genes on two different plasmids.

Authors:  D Markowitz; S Goff; A Bank
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

View more
  18 in total

1.  A virus-virus interaction circumvents the virus receptor requirement for infection by pathogenic retroviruses.

Authors:  David L Wensel; Weihua Li; James M Cunningham
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  G100R mutation within 4070A murine leukemia virus Env increases virus receptor binding, kinetics of entry, and viral transduction efficiency.

Authors:  Chi-Wei Lu; Lucille O'Reilly; Monica J Roth
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Modular organization of the Friend murine leukemia virus envelope protein underlies the mechanism of infection.

Authors:  A L Barnett; R A Davey; J M Cunningham
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

4.  Role of the mutation Q252R in activating membrane fusion in the murine leukemia virus surface envelope protein.

Authors:  Chi-Wei Lu; Monica J Roth
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

5.  Three distinct envelope domains, variably present in subgroup B feline leukemia virus recombinants, mediate Pit1 and Pit2 receptor recognition.

Authors:  S Boomer; M Eiden; C C Burns; J Overbaugh
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

6.  Identification of envelope protein residues required for the expanded host range of 10A1 murine leukemia virus.

Authors:  J Y Han; P M Cannon; K M Lai; Y Zhao; M V Eiden; W F Anderson
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

7.  Identification of envelope determinants of feline leukemia virus subgroup B that permit infection and gene transfer to cells expressing human Pit1 or Pit2.

Authors:  J Sugai; M Eiden; M M Anderson; N Van Hoeven; C D Meiering; J Overbaugh
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

8.  Identification of a retroviral receptor used by an envelope protein derived by peptide library screening.

Authors:  Anindita Sarangi; Keith Bupp; Monica J Roth
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-20       Impact factor: 11.205

9.  Second-site changes affect viability of amphotropic/ecotropic chimeric enveloped murine leukemia viruses.

Authors:  L O'Reilly; M J Roth
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

10.  The MuLV 4070A G541R Env mutation decreases the stability and alters the conformation of the TM ectodomain.

Authors:  William M Schneider; Haiyan Zheng; Marie L Coté; Monica J Roth
Journal:  Virology       Date:  2007-10-24       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.